SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4224Vicuron Pharmaceuticals Announces Phase 3 Trial Results Demonstrate Superiority scaram(o)uche2/7/2005
4223from this week's BioCentury (thanks, R!), second best January for the sectorscaram(o)uche2/7/2005
4222Threshold Pharmaceuticals 5.3M-Shr IPO Priced At $7 DOW JONES NEWSWIRES Februarmopgcw2/4/2005
4221from briefing: 10:53 ET Icagen IPO prices below range; biotech (ICGN) 8.00: Icagsjemmeri2/3/2005
4220>> Keep in mind this is a Nov '04 filing << ok, thanks.scaram(o)uche2/3/2005
4219added decent size of ntii too. not familiar with Icoria (paradigm genetics) omopgcw2/3/2005
4218Aeolus Pharmaceuticals New Name and Trading Symbol Effective Today Research Trimopgcw2/3/2005
4217Is Aeolus the old Incara? Interesting. bought acadia, arqule, flamel and kosanscaram(o)uche2/3/2005
4216>> no more puts << good. thanks for the update!scaram(o)uche2/3/2005
4215Note BVF filed on a bunch of warrants on Aerogen. Took a look at the last two &mopgcw2/3/2005
4214Biotech IPOs Face Market Plagued By Investor Fatigue By LYNN COWAN February 2, mopgcw2/3/2005
4213Calif. Court Sets Aside Genentech Verdict Wednesday February 2, 8:08 pm ET Calscaram(o)uche2/2/2005
4212Vasogen Completes US$42.3 Million Registered Direct Offering of Common Shares Wescaram(o)uche2/2/2005
4211Message 21007657scaram(o)uche2/2/2005
4210Favrille Cuts IPO Price To $8-$9 A Share From $12-$14 DOW JONES NEWSWIRES Februmopgcw2/2/2005
4209Thanks for posting that here. I would have blanked, and it's definitely parscaram(o)uche2/1/2005
4208Arena Pharm Holder Accipiter Capital Opposes Offering DOW JONES NEWSWIRES Januamopgcw2/1/2005
4207<i>E' finita la commedia... Not yet :</i> BERKELEY, Calif.--(Bnigel bates1/31/2005
4206Myelin Repair Foundation Announces $250,000 Research Award from Biogen Idec Mondscaram(o)uche1/31/2005
4205Michael J. Fox Foundation Boosts Stem Cell Research in Parkinson's and Awardscaram(o)uche1/31/2005
4204Very interesting: that article caused me to buy SEPR, AIMM (sigh), and AVM. I&#Sidney Street1/31/2005
4203combidex was just taking too long. thought there were better oppportunities at mopgcw1/31/2005
4202How come out on AVM?Extra Pale1/31/2005
4201me too. I bought dianon, avm, and celtrix (now insmd) based on that article. himopgcw1/31/2005
4200Rick, BVF/Lampert turned me on to bio investing in mid-90s. Barrons feature piecExtra Pale1/31/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News